Zheng, B., Green, A. C. A., Tazare, J., Curtis, H. J., Fisher, L., Nab, L., Schultze, A., Mahalingasivam, V., Parker, E. P. K., Hulme, W. J., Bacon, S. C. J., DeVito, N. J., Bates, C., Evans, D., Inglesby, P., Drysdale, H., Davy, S., Cockburn, J., Morton, C. E., Hickman, G., Ward, T., Smith, R. M., Parry, J., Hester, F., Harper, S., Mehrkar, A., Eggo, R. M., Walker, A. J., Evans, S. J. W., Douglas, I. J., MacKenna, B., Goldacre, B., & Tomlinson, L. A. (2022). comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform. BMJ, 379, . http://access.bl.uk/ark:/81055/vdc_100169753361.0x00005e